 CAMBRIDGE, Mass., March 04, 2021 GLOBE NEWSWIRE -- Solid Biosciences Inc. Nasdaq: SLDB, a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy Duchenne, today announced the grant of an inducement award to its newly appointed Chief Legal Officer, Erin Brennan. The grant was approved by a majority of the independent directors of the Company on February 25, 2021 as an inducement material to Ms. Brennan entering into employment with the Company in accordance with Nasdaq Listing Rule 5635c4. 